James P. Hartman has been appointed vice president of medical dermatology at Merz, Inc. (a division of Merz Pharma Group) effective June 12, 2012. Hartman will be responsible for the company's Medical and OTC/OTX dermatology business unit, which includes Naftin (naftifine hydrochloride) and Mederma.
“Jim has a proven track record when it comes to developing and commercializing pharmaceutical and OTC/OTX products,” said Bill Humphries, president/CEO of Merz. “We are extremely pleased to have him join the Merz team and are confident he will make immediate and important contributions to the continued growth of our medical dermatology business and the company as a whole."
Hartman holds a Bachelor of Arts degree in Social Science from the University of California at Irvine. Prior to joining Merz, he was vice president, global marketing & business development, at Obagi Medical Products. Previously, he was senior vice president, U.S. commercial operations, and vice president of U.S. marketing for Stiefel Laboratories. Hartman also has held senior-level positions with Allergan and SmithKline Beecham (now GlaxoSmithKline). He will be based at Merz offices in Greensboro, NC.